August 30, 2017

Boehringer Ingelheim Unveils New Brand Platform: Unbridle Your Potential

DULUTH, GA (August 30, 2017) —  In early 2017, Boehringer Ingelheim (BI) acquired Merial, becoming the leader in equine health. As we have begun work to create the new Boehringer Ingelheim, an opportunity to leverage the knowledge and expertise from both companies emerged, as did the responsibility to provide support and leadership for the entire equine industry. To illustrate that responsibility, BI is introducing its new brand platform: Unbridle Your Potential. In short, BI provides health care products that will help unlock the potential in each horse.

Every BI brand plays a role in helping horses reach their potential. As the leading equine health company in the United States, BI recognizes that the community that cares for horses day in and day out requires products that are trusted to perform, allowing each horse to achieve its potential. Unbridle Your Potential is about bringing out the best in everyone – veterinarians, horse owners, trainers and the horses we all love.

The Boehringer Ingelheim equine portfolio consists of:

  • GastroGard® (omeprazole) and UlcerGard® (omeprazole)
  • Vaccines including Vetera® and Calvenza®
  • A joint health portfolio that includes Legend® (hyaluronate sodium) Injectable Solution, Hyvisc® (hyaluronate sodium), Hyalovet® (hyaluronate sodium), Vetalog® Parenteral (triamcinolone acetonide injectable suspension), Surpass® (1% diclofenac sodium) and Equioxx® (firocoxib)
  • Prascend® (pergolide tablets)
  • Marquis® (15% w/w ponazuril)
  • Zimecterin® Gold (ivermectin/praziquantel) and ZIMECTERIN (ivermectin)

“We’re excited about this new brand platform as it represents our leadership in the equine health industry and the understanding that everyone who cares for horses wants to see each animal do its best,” says Dave Gocken, species head of the U.S. Equine Business Unit, Boehringer Ingelheim. “Whether it’s racing, performing, trail riding or any other number of activities, our products give everyone the opportunity to reach their potential. At its core, Unbridle Your Potential is about the passion people have in caring for their horses, and we’re pleased to help bring that passion to life with our leading product line-up.”

For more information, please contact:

Stephanie Hoult
PR Content Supervisor 
Michele Egan
Senior Marketing Communications Manager 
Boehringer Ingelheim Animal Health 
Rene Ward
U.S. Communications 
Boehringer Ingelheim Animal Health 

Vetalog and Surpass are registered trademarks of Boehringer Ingelheim Vetmedica, Inc.
Vetera, Calvenza and Prascend are registered trademarks of Boehringer Ingelheim Vetmedica GmbH.
GastroGard, UlcerGard, Legend, Equioxx, Marquis and Zimecterin are registered trademarks of Merial, Inc.
Hyalovet is a registered trademark of TRB Chemedica International S.A., Geneva Switzerland, used under license.
Hyvisc is a registered trademark of Anika Therapeutics, Inc., used under license.